[Adaptation of platelet concentrates delivery to HAS/ANSM requirements evolution in EFS Grand-Est].
Fiche publication
Date publication
juillet 2018
Journal
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GACHET Christian
Tous les auteurs :
Kientz D, Humbrecht C, Isola H, Gachet C
Lien Pubmed
Résumé
Evolution of French HAS/ANSM guidelines in 2015 about optimal platelet transfusion dose for patients brought us to review about our practices for platelet concentrates delivery in EFS Grand-Est region. In addition, pathogen inactivation in platelet concentrates has been implemented all over the country and transfusion centers have merged. All these changes required harmonization. In this context, our major issue was to answer patient's requirements, according to the new guidelines keeping in mind the cost effectiveness on public finances. We report here on the changes in our practices and their impacts.
Mots clés
Blood component production, Concentrés plaquettaires, Delivery, Dose transfusionnelle, Délivrance, Platelet concentrates, Platelet doses, Production
Référence
Transfus Clin Biol. 2018 Jul 16;: